首页|卵巢良恶性肿瘤的超声征象及其与卵巢癌临床分期、病理分级的相关性分析

卵巢良恶性肿瘤的超声征象及其与卵巢癌临床分期、病理分级的相关性分析

扫码查看
目的:探讨卵巢肿瘤良恶性病变的超声征象及其与卵巢癌临床分期、病理分级的相关性。方法:选取我院2020年8月到2023年8月收治的148例卵巢肿瘤患者进行回顾性分析,以手术病理及病理活检作为诊断金标准,将60例确诊为卵巢癌的患者纳入恶性组,将88例确诊为卵巢良性肿瘤的患者纳入良性组。对所有患者进行超声检查,分析其超声图像特征。随后分析60例卵巢癌患者不同临床分期和病理分级患者的超声诊断参数情况,并分析超声诊断相关参数与卵巢临床分期、病理分级的相关性。结果:超声对卵巢肿瘤良性诊断准确率为86。36%(76/88)对恶性肿瘤诊断率为88。64%(78/88);不同临床分期患者RI、PI、EDV、PSV 对比差异显著,Ⅰ 期患者 RI、PI 为(0。77±0。14)和(1。67±0。24)高于Ⅱ期(0。64±0。15)和(1。25±0。16)、Ⅲ 期患者(0。52±0。17)和(0。96±0。16)、Ⅳ期(0。41±0。12)和(0。76±0。12),Ⅰ 期患者 EDV 和 PSV(8。63±1。27)cm/s 和(16。53±2。53)cm/s 低于 Ⅱ 期(10。25±1。68)cm/s 和(18。44±1。58)cm/s、Ⅲ期(12。73±1。79)cm/s 和(20。14±2。25)cm/s、Ⅳ期患者(15。51±1。12)cm/s 和(23。06±1。98)cm/s(P<0。05);不同临床分期患者RI、PI、EDV、PSV对比差异显著,Ⅰ级患者RI、PI为(0。81±0。16)和(1。62±0。19)高于Ⅱ级(0。65±0。12)和(0。91±0。22)、Ⅲ级患者(0。47±0。17)和(0。67±0。13),Ⅰ 级患者 EDV 和 PSV(8。32±1。51)cm/s 和(15。12±3。33)cm/s低于Ⅱ级(12。75。±1。14)cm/s 和(21。31±3。14)cm/s、Ⅲ级患者(15。35±1。79)cm/s 和(24。08±2。04)cm/s(P<0。05);Spearman 相关分析结果表明:临床分期、病理分级与RI、PI呈负相关,与EDV、PSV呈正相关(P<0。05)。结论:超声对卵巢肿瘤的良恶性病变诊断具有重要指导价值,且与卵巢癌的临床分期、病理分级具有明显相关性,值得临床应用推广。
Analysis of Ultrasound Signs of Benign and Malignant Tumors of the Ovary and Their Correlation with Clinical Stage and Pathological Grading of Ovarian Cancer
Objective:To investigate the ultrasound signs of benign and malignant lesions of ovarian tumors and their correlation with clinical staging and pathological grading of ovarian cancer.Methods:148 patients with ovarian tumors admitted to our hospital from August 2020 to August 2023 were selected for retrospective analysis,and surgical pathology and pathological biopsy were used as the gold standard for diagnosis,60 patients diagnosed with ovarian cancer were included in the malignant group,and 88 patients diagnosed with benign ovarian tumors were included in the benign group.Ultrasonography was performed on all patients and their ultrasound image characteristics were analyzed.Subsequently,the ultrasound diagnostic parameters of 60 patients with ovarian cancer in different clinical stages and pathological grades were analyzed,and the correlation between ultrasound diagnostic related parameters and ovarian clinical stages and pathological grades was analyzed.Results:The accuracy of ultrasound in the diagnosis of benign ovarian tumors was 86.36%(76/88),while the diagnostic rate of malignant tumors was 88.64%(78/88);There were significant differences in the comparison of RI,PI,EDV,and PSV among patients with different clinical stages.The RI and PI of stage Ⅰ patients were(0.77±0.14)and(1.67±0.24)higher than those of stage Ⅱ patients(0.64±0.15)and(1.25±0.16),stage Ⅲ patients(0.52±0.17)and(0.96±0.16),stage Ⅳ patients(0.41±0.12)and(0.76±0.12).The EDV and PSV of stage Ⅰ patients were(8.63±1.27)cm/s and(16.53±2.53)cm/s lower than those of stage Ⅱ patients(10.25±1.68)cm/s and(18.44±1.58)cm/s Phase Ⅲ patients(12.73±1.79)cm/s and(20.14±2.25)cm/s,and Phase Ⅳpatients(15.51±1.12)cm/s and(23.06±1.98)cm/s(P<0.05);There were significant differences in the comparison of RI,PI,EDV,and PSV among patients with different clinical stages.The RI and PI of grade Ⅰ patients were(0.81±0.16)and(1.62±0.19)higher than those of grade Ⅱ patients(0.65±0.12)and(0.91±0.22),grade Ⅲ patients(0.47±0.17)and(0.67±0.13).The EDV and PSV of grade Ⅰ pa-tients were(8.32±1.51)cm/s and(15.12±3.33)cm/s lower than those of grade Ⅱ patients(12.75±1.14)cm/s and(21.31±3.14)cm/s Grade Ⅲ patients(15.35±1.79)cm/s and(24.08±2.04)cm/s,(P<0.05);The Spearman correlation analysis results showed that clinical staging and pathological grading were negatively correlated with RI and PI,but positively correlated with EDV and PSV(P<0.05).Con-clusion:Ultrasound has important guiding value in the diagnosis of benign and malignant ovarian tumors,and has a significant correla-tion with the clinical staging and pathological grading of ovarian cancer,which is worthy of clinical application and promotion.

Ovarian tumorsOvarian cancerClinical stagingPathological gradingCorrelationultrasonic

问姣、郭怡、张倩、苏雪、段绍雪

展开 >

西北妇女儿童医院医学超声中心 陕西西安 710038

西北妇女儿童医院妇三科 陕西西安 710038

西北妇女儿童医院病理科 陕西西安 710038

陕西省肿瘤医院超声科 陕西西安 710061

展开 >

卵巢肿瘤 卵巢癌 临床分期 病理分级 相关性 超声

陕西省卫生健康科研项目

2022D054

2024

现代生物医学进展
黑龙江省森工总医院 哈尔滨医科大学附属第四医院

现代生物医学进展

CSTPCD
影响因子:0.755
ISSN:1673-6273
年,卷(期):2024.24(12)